title: [The role of the von Willebrand factor in renal diseases and haemodialysis patients].
abstract: During a period of twenty years, the von Willebrand factor (VWf) biological activity was evaluated in 805 patients with vein thrombosis, diabetes mellitus, chronic renal failure and ischemic heart disease. The examined patients were 168 with vein thrombosis, 129 with diabetes mellitus, 412 with chronic renal failure (CRF), and 96 with ischemic heart disease. The biological activity was also determined in 104 haemodialysis patients using four different haemodialytic membranes: 30 on cuprophan membrane, 30 on polymethylmetacrylate membrane (PMMA), 24 on hemophane and 20 patients on polysulphone (PS) membrane. In 42 patients with arterio-venous fistula prone to thrombosis, the biological activity of the von Willebrand Factor was 178% in comparison to 106% in the control group. The biological activity of VWF was increased in patients with vein thrombosis (p < 0.02), in patients with diabetes mellitus (p < 0.01), CRF (p < 0.05), and in patients with ischemic heart disease (p < 0.01). The highest biological activity was found in patients on PMMA (p < 0.001), then cuprophan (p < 0.05) and hemophane membrane (p < 0.01), while the lowest increase of its concentration was noticed in patients on PS without statistical significance. In arteriovenous fistula prone to thrombosis patients biological activity of the von Willebrand Factor was significantly increased (p < 0.01). Our investigations show the importance of VWF as a marker of endothelial disfunction, a possible predictor of A-V fistula thrombosis, and a possible marker of haemodialysis membranes biocompatibility.
authors.forename: P
authors.initials: P
authors.lastname: Dejanov
authors.forename: M
authors.initials: M
authors.lastname: Polenaković
authors.forename: A
authors.initials: A
authors.lastname: Oncevski
authors.forename: A
authors.initials: A
authors.lastname: Sikole
authors.forename: B
authors.initials: B
authors.lastname: Dejanova
authors.forename: S
authors.initials: S
authors.lastname: Panov
authors.forename: S
authors.initials: S
authors.lastname: Kostovska
mesh_terms: D003920:Diabetes Mellitus / Q000097:blood; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood*; D017202:Myocardial Ischemia / Q000097:blood; D006435:Renal Dialysis; D020246:Venous Thrombosis / Q000097:blood; D014841:von Willebrand Factor / Q000032:analysis*
chemical_list: D014841:von Willebrand Factor